Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia

Clinical trial NCT01334723 · COMPLETED

Trial details

NCT number: NCT01334723
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Hyperplasia

Start date: 2010-04-01
Primary completion: 2010-04-01
Enrollment: 35032

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.